Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report
Background The risk of stroke is heterogeneous across different groups of patients with atrial
fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide …
fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide …
Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis
X Gong, S Tang, J Li, X Zhang, X Tian, S Ma - PLoS One, 2017 - journals.plos.org
Objective The aim of this systematic review and network meta-analysis was to evaluate the
comparative efficacy and safety of antiplatelet agents, vitamin K antagonist (VKA) and non …
comparative efficacy and safety of antiplatelet agents, vitamin K antagonist (VKA) and non …
[HTML][HTML] Exploration of PCSK9 as a cardiovascular risk factor: is there a link to the platelet?
Thrombus generation leading to cardiovascular event (CVE) occurrence involves a complex
interplay among platelets, coagulation factors, and leukocytes (1, 2). It has been reported …
interplay among platelets, coagulation factors, and leukocytes (1, 2). It has been reported …
Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous …
J Park, JH Jung, EK Choi, SW Lee, S Kwon, SR Lee… - PloS one, 2022 - journals.plos.org
Background and objective Most Asian patients with atrial fibrillation (AF) who undergo
percutaneous coronary intervention (PCI) receive only dual antiplatelet therapy (DAPT) …
percutaneous coronary intervention (PCI) receive only dual antiplatelet therapy (DAPT) …
Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
L Wei, E Su, W Liu, W Xing, X Liu, Y Zhang… - BMC cardiovascular …, 2020 - Springer
Background Coronary artery disease (CAD) and atrial fibrillation (AF) frequently coexist in
clinical practice, making it challenging for the treating physician to choose anticoagulation …
clinical practice, making it challenging for the treating physician to choose anticoagulation …
Effects of atrial fibrillation on complications and prognosis of patients receiving emergency PCI after acute myocardial infarction
Y Zhang, L Zhang, HZ Zheng… - Experimental and …, 2018 - spandidos-publications.com
The effects of atrial fibrillation on complications and prognosis of patients receiving
emergency percutaneous coronary intervention after acute myocardial infarction (AMI) were …
emergency percutaneous coronary intervention after acute myocardial infarction (AMI) were …
An analysis of antithrombotic therapy in elderly patients with atrial fibrillation undergoing percutaneous coronary interventions
J Zhou, X Wang, J Yu, Y Wu, X Li, X Xie… - Clinical and …, 2023 - Wiley Online Library
As a result of large, randomized trials and updates to clinical guidelines, antithrombotic
therapy following percutaneous coronary intervention (PCI) has changed in recent years for …
therapy following percutaneous coronary intervention (PCI) has changed in recent years for …
Dual versus triple antithrombotic therapy after percutaneous coronary intervention or acute coronary syndrome in patients with indication for anticoagulation: an …
D Shin, BD Mohanty, ES Lee - Coronary artery disease, 2018 - journals.lww.com
Background For patients who have an indication for anticoagulation, it is controversial
whether dual therapy with an oral anticoagulant and single antiplatelet agent can be used …
whether dual therapy with an oral anticoagulant and single antiplatelet agent can be used …
[HTML][HTML] Increased bleeding events with the addition of apixaban to the dual anti-platelet regimen for the treatment of patients with acute coronary syndrome: a meta …
J Jin, X Zhuo, M Xiao, Z Jiang, L Chen, YD Shamloll - Medicine, 2021 - journals.lww.com
Background: Dual anti-platelet therapy (DAPT) with aspirin and clopidogrel has been the
mainstay of treatment for patients with acute coronary syndrome (ACS). However, the …
mainstay of treatment for patients with acute coronary syndrome (ACS). However, the …
Omission of aspirin in patients taking oral anticoagulation after percutaneous coronary intervention: a systematic review and meta-analysis
J Zhang, Z Wang, W Sang, M Wei, F Xu… - Coronary Artery …, 2019 - journals.lww.com
Methods We identified randomized controlled trials (RCTs) published in PubMed, Cochrane
Library, and Embase using the following keywords:'antiplatelet','dual therapy','triple therapy',' …
Library, and Embase using the following keywords:'antiplatelet','dual therapy','triple therapy',' …